At PlexusDx, we understand that every weight loss journey is unique
Despite the growing presence of compounded GLP-1s, switching to branded alternatives remains rare
Last year, the World Health Organization (WHO) issued its first guideline endorsing GLP-1 therapies for the long-term treatment of obesity, recognizing it as a chronic disease and recommending these agents as part of comprehensive management strategies that include diet, physical activity, and structured care
Funding The author(s) declare that no financial support was received for the research, and/or publication of this article
Interestingly, the most striking respiratory difference attributable to loss of GSH emerged upon treatment of Gclc fl/fl and Gclc fl/fl Mb1-Cre + FoB with the mitochondrial ionophore FCCP, which increases the OCR to the maximal respiration (i.e
Additionally, both substances influence blood glucose homeostasis, though through different mechanisms